The rising power of several major drug corporations is sparking grave worries internationally. This trend towards domination frequently contributes to escalated prescription prices, reduced development, and challenges in obtaining critical treatments for people in the world. Analysts suggest that enhanced scrutiny here is required to address these

India's pharmaceutical landscape presents a complex picture, largely shaped by the significant influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These traditional companies, including entities l